Zobrazeno 1 - 10 of 38 pro vyhledávání: '"C van der Woude"'
1
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry
Autor: Tessa Straatmijer, Fiona D. M. van Schaik, Alexander G. L. Bodelier, Marijn Visschedijk, Annemarie C. de Vries, Cyriel Y. Ponsioen, Marieke Pierik, Ad A. van Bodegraven, Rachel L. West, Nanne K. H. de Boer, Nidhi Srivastava, Tessa E. H. Romkens, Jildou Hoekstra, Bas Oldenburg, Gerard Dijkstra, Janneke C. van der Woude, Mark Löwenberg, Zlatan Mujagic, Vince B. C. Biemans, Andrea E. van der Meulen‐de Jong, Marjolijn Duijvestein
Publikováno v: Alimentary Pharmacology & Therapeutics, 57, 1, pp. 117-126
Alimentary Pharmacology & Therapeutics, 57, 117-126
Alimentary Pharmacology and Therapeutics, 57(1), 117-126
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. Wiley-Blackwell
Straatmijer, T, van Schaik, F D M, Bodelier, A G L, Visschedijk, M, de Vries, A C, Ponsioen, C Y, Pierik, M, van Bodegraven, A A, West, R L, de Boer, N K H, Srivastava, N, Romkens, T E H, Hoekstra, J, Oldenburg, B, Dijkstra, G, van der Woude, J C, Löwenberg, M, Mujagic, Z, Biemans, V B C, van der Meulen-de Jong, A E & Duijvestein, M 2023, ' Effectiveness and safety of tofacitinib for ulcerative colitis : two-year results of the ICC Registry ', Alimentary Pharmacology and Therapeutics, vol. 57, no. 1, pp. 117-126 . https://doi.org/10.1111/apt.17248
Alimentary Pharmacology & Therapeutics, 57(1), 117-126. Wiley
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology and Therapeutics, 57(1), 117-126. WILEY
Contains fulltext : 290620.pdf (Publisher’s version ) (Open Access) BACKGROUND: Tofacitinib is an oral Janus kinase (JAK) inhibitor and is registered for the treatment of ulcerative colitis (UC). The effectiveness of tofacitinib has been evaluated
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8627fcaccc449fd1031dddee12b17e7
https://doi.org/10.1111/apt.17248
Zobrazit plný text záznamu
2
DOP75 Effectiveness and Safety of tofacitinib versus vedolizumab in Patients with Ulcerative Colitis; A Nationwide, ICC Registry study
Autor: T Straatmijer, M Visschedijk, A de Vries, F Hoentjen, A A van Bodegraven, A G L Bodelier, N K H de Boer, G Dijkstra, E A M Festen, C Horjus, J M Jansen, B Jharap, W Mares, B Oldenburg, C Y Ponsioen, T E H Romkens, N Srivastava, M M van der Voorn, R L West, J C van der Woude, M D J Wolvers, M Pierik, A E van der Meulen, M Duijvestein
Publikováno v: Journal of Crohn's and Colitis. 16:i118-i120
Background Clinicians face difficulty in positioning biologics and JAK inhibitors in anti-TNF refractory ulcerative colitis (UC) patients. Head-to-head trials comparing the efficacy of vedolizumab and tofacitinib in UC patients are lacking. We aimed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::587c6d39aa1abb6cf5ebacdc5b22aa05
https://doi.org/10.1093/ecco-jcc/jjab232.114
Zobrazit plný text záznamu
7
Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk
Autor: Eleonora A M, Festen, Pieter C F, Stokkers, Cleo C, van Diemen, Adriaan A, van Bodegraven, H Marieke, Boezen, Bart J A, Crusius, Daniel W, Hommes, C Janneke, van der Woude, Janneke C, van der Woude, Tobias, Balschun, Hein W, Verspaget, Stephan, Schreiber, Dirk J, de Jong, Andre, Franke, Gerard, Dijkstra, Cisca, Wijmenga, Rinse K, Weersma
Publikováno v: American Journal of Gastroenterology, 105(2), 395-402. Springer Nature
American Journal of Gastroenterology, 105, 395-402
Festen, E A, Stokkers, P C, van Diemen, C C, van Bodegraven, A A, Boezen, H M, Crusius, J B A, Hommes, DW, van der Woude, J, Balschun, T, Verspaget, H W, Schreiber, S, Jong, D J, Franke, A, Dijkstra, G, Wijmenga, C & Weersma, R K 2010, ' Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk ', American Journal of Gastroenterology, vol. 105, no. 2, pp. 395-402 . https://doi.org/10.1038/ajg.2009.576
American journal of gastroenterology, 105(2), 395-402. Springer Nature
AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(2), 395-402. LIPPINCOTT WILLIAMS & WILKINS
American Journal of Gastroenterology, 105(2), 395-402
American Journal of Gastroenterology, 105, 2, pp. 395-402
Item does not contain fulltext OBJECTIVES: Genetic susceptibility is known to make a major contribution to the pathogenesis of ulcerative colitis (UC). Recently, three studies, including a genome-wide association study (GWAS), reported novel UC risk
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bddd0e6b3c80a5322e5eccb52878843
https://doi.org/10.1038/ajg.2009.576
Zobrazit plný text záznamu
9
From hospital deliveries to home birth
Autor: C, Van Der Woude
Publikováno v: The Journal of perinatal education. 10(3)
Working in a busy labor/delivery unit gave me insight into the care that my Lamaze childbirth education students would encounter. I was troubled by the number of interventions taking place. The interventions interfered with a woman's ability to work
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c2b45ae66d8affe0e5cfe13bb3fd3e2
https://pubmed.ncbi.nlm.nih.gov/17273264
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje